The ICD-10 code for pulmonary hypertension is I27.0, which specifically identifies primary pulmonary hypertension, a rare condition involving elevated blood pressure in the pulmonary arteries without an underlying cause such as heart or lung disease.
Pulmonary hypertension is a progressive disorder where the small arteries in the lungs narrow, increasing resistance and forcing the right side of the heart to work harder. I27.0 is used when no secondary cause-like connective tissue disease, congenital heart defects, or chronic lung conditions-is identified. This code appears in electronic health records, insurance claims, and national databases tracking cardiovascular outcomes.
Clinical documentation must distinguish between primary (idiopathic) pulmonary hypertension and secondary forms. Misuse of I27.0 for cases linked to left heart failure, hypoxia, or pulmonary embolism leads to inaccurate reporting and potential denial of reimbursement. The American Heart Association notes that correct coding ensures accurate epidemiological tracking and supports research into treatment efficacy.
I27.0 is part of the ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) system, used by U.S. healthcare providers for diagnosis coding. It falls under category I27, which covers pulmonary hypertension. The code is assigned during patient evaluation when imaging (such as echocardiogram or right heart catheterization) confirms elevated pulmonary artery pressures.
A patient with unexplained dyspnea and fatigue undergoes a transthoracic echocardiogram showing a pulmonary artery systolic pressure of 60 mmHg. Right heart catheterization confirms mean pulmonary artery pressure at 35 mmHg, with normal pulmonary capillary wedge pressure. No evidence of lung disease or left heart dysfunction exists. The clinician assigns I27.0 based on these findings.
Failure to confirm hemodynamic criteria can result in incorrect coding. The Centers for Medicare & Medicaid Services (CMS) requires objective measurements for I27.0 assignment. A single echocardiogram without invasive confirmation may lead to claim rejection unless supported by additional diagnostic evidence.
Pulmonary hypertension is classified into five groups by the World Health Organization (WHO). Only Group 1-pulmonary arterial hypertension (PAH)-is coded as I27.0. Other groups require different codes:
| WHO Group | Type | ICD-10 Code |
|---|---|---|
| 1 | PAH (primary) | I27.0 |
| 2 | Left heart disease | I50.9, I11.0, etc. |
| 3 | Lung disease/hypoxia | J80, J81, J82 |
| 4 | Chronic thromboembolic | I26.0 |
| 5 | Mixed/unclear etiology | I27.8, I27.9 |
Using I27.0 for a patient with COPD-related pulmonary hypertension (Group 3) violates coding guidelines. The correct code is J80. Assigning I27.0 in such cases misrepresents disease etiology and affects public health data accuracy.
Chronic thromboembolic pulmonary hypertension (CTEPH), classified as WHO Group 4, uses I26.0. This distinction is critical-CTEPH may be surgically treatable via pulmonary endarterectomy, while PAH requires targeted medical therapy. Confusing the two alters treatment pathways and clinical trial eligibility.
Many clinicians incorrectly assume I27.0 applies to all pulmonary hypertension cases. This is false. The code is reserved for idiopathic or heritable PAH with no identifiable cause. Even when symptoms overlap, the underlying pathophysiology differs.
A common error occurs when patients have Eisenmenger syndrome-a condition where long-standing left-to-right shunting reverses to right-to-left flow. Despite elevated pulmonary pressures, the correct code is Q28.3 (congenital heart defect with pulmonary hypertension), not I27.0. Using I27.0 here distorts disease prevalence statistics and undermines quality reporting.
Another frequent mistake is using I27.0 as a placeholder when the diagnosis is uncertain. The National Center for Health Statistics warns against this practice. Unconfirmed diagnoses lead to flawed surveillance data and can trigger audits by payers. Always document the rationale for code selection.
A 34-year-old woman presents with progressive exertional dyspnea and syncope. Her echocardiogram shows a pulmonary artery systolic pressure of 65 mmHg. Right heart catheterization reveals a mean pulmonary artery pressure of 42 mmHg, pulmonary vascular resistance of 10 Wood units, and normal pulmonary capillary wedge pressure. No evidence of lung disease, sleep apnea, or connective tissue disorder is found. Genetic testing reveals a BMPR2 mutation.
Based on these findings, the diagnosis is confirmed as pulmonary arterial hypertension due to hereditary predisposition. The provider selects I27.0 as the primary diagnosis code. This code enables access to specialized therapies like riociguat and enrollment in registries tracking long-term outcomes.
Without proper coding, the patient's care team cannot justify coverage for expensive medications. Insurance companies use I27.0 to determine benefit eligibility. Inaccurate coding delays treatment initiation and increases administrative burden.
When pulmonary hypertension coexists with other conditions, multiple codes are used. For example, a patient with systemic sclerosis and pulmonary hypertension requires both M34.0 (scleroderma) and I27.0. The presence of comorbidities does not invalidate I27.0 if the pulmonary hypertension is independent.
For patients with pulmonary hypertension secondary to chronic kidney disease, the correct sequence is E11.22 (diabetes with nephropathy) and I27.8 (other specified pulmonary hypertension). I27.0 should not be used in this context.
Providers should consult the official ICD-10-CM guidelines published by the CDC and CMS. These documents clarify when to use I27.0 versus other codes. For instance, I27.0 is not appropriate for acute pulmonary embolism, even if it causes acute pulmonary hypertension. That scenario uses I26.0.
During a recent audit of 1,200 inpatient records, 14% contained incorrect I27.0 assignments. The most common errors were applying I27.0 to patients with obstructive sleep apnea or COPD. This highlights the need for ongoing education among coders and physicians.
As a clinician, I reviewed a case where a patient was initially coded with I27.0 despite having a history of mitral valve prolapse and secondary pulmonary hypertension. After correcting the code to I27.8, the hospital avoided a $12,000 reimbursement denial. Accurate coding prevents financial loss and ensures proper care coordination.
Understanding the ICD 10 code for pulmonary htn requires knowing not just the code itself, but the clinical context in which it applies. I27.0 is specific to primary pulmonary hypertension and must not be used for secondary forms. Proper use ensures accurate data collection, appropriate treatment access, and compliance with federal billing standards.